Sam Tsimikas, MD

SVP, Global Cardiovascular Development
Ionis Pharmaceutical

Poster(s):

• (41) Olezarsen and plozasiran in the treatment of familial chylomicronemia syndrome (FCS): Results from a matching-adjusted indirect comparison (MAIC)
  Wednesday, October 29, 2025